Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality
- PMID: 14607434
- DOI: 10.1016/j.jacc.2003.06.001
Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality
Abstract
Objectives: We hypothesized that impaired renal function would also be associated with poorer clinical outcomes among patients with ST-segment elevation myocardial infarction (STEMI) treated with fibrinolysis.
Background: Previous studies have demonstrated that impaired renal function is associated with poorer clinical outcomes in the setting of unstable angina and non-STEMI and after percutaneous coronary intervention.
Methods: Data were drawn from the Thrombolysis In Myocardial Infarction (TIMI)-10, TIMI-14, and Intravenous nPA for the Treatment of Infarcting Myocardium Early (InTIME-II) trials.
Results: Within each TIMI risk score (TRS) for STEMI category (0 to 2, 3 to 4, >/=5), 30-day mortality increased stepwise among patients with normal (creatinine [Cr] </=1.2 mg/dl), mildly (Cr >1.2 to 2 mg/dl), and severely (Cr >2.0 mg/dl) impaired renal function (p < 0.001) and in patients with normal (creatinine clearance [CrCl] >/=90 ml/min), mildly (60 to <90 ml/min), moderately (30 to <60 ml/min), and severely (<30 ml/min) impaired CrCl (p < 0.001). Impaired renal function was associated with increased mortality after adjusting for previously identified correlates of mortality (using Cr: odds ratio [OR] for mild impairment 1.52, 95% confidence interval [CI] 1.30 to 1.77, p < 0.001; OR for severe impairment 3.73, 95% CI 2.55 to 5.45, p < 0.001; using CrCl: OR for mild impairment 1.38, 95% CI 1.10 to 1.73, p = 0.006; OR for moderate impairment 2.06, 95% CI 1.59 to 2.66, p < 0.001; OR for severe impairment 3.81, 95% CI 2.57 to 5.65, p < 0.001).
Conclusions: In the setting of STEMI, elevated Cr and/or impaired CrCl on presentation is associated with increased mortality, independent of other conventional risk factors and TRS. This association does not appear to be mediated by reduced fibrinolytic efficacy among patients with impaired renal function or by the presence of congestive heart failure on presentation.
Comment in
-
Renal insufficiency and worsened prognosis with STEMI: a call for action.J Am Coll Cardiol. 2003 Nov 5;42(9):1544-6. doi: 10.1016/j.jacc.2003.08.001. J Am Coll Cardiol. 2003. PMID: 14607435 No abstract available.
Similar articles
-
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.Am Heart J. 2009 Mar;157(3):517-24. doi: 10.1016/j.ahj.2008.10.021. Am Heart J. 2009. PMID: 19249423
-
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.Am J Cardiol. 2004 Nov 1;94(9):1113-7. doi: 10.1016/j.amjcard.2004.07.075. Am J Cardiol. 2004. PMID: 15518603 Clinical Trial.
-
Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.J Invasive Cardiol. 2009 Oct;21(10):493-8. J Invasive Cardiol. 2009. PMID: 19805833
-
Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.Am J Cardiovasc Drugs. 2004;4(2):107-15. doi: 10.2165/00129784-200404020-00004. Am J Cardiovasc Drugs. 2004. PMID: 15049722 Review.
-
Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.Cochrane Database Syst Rev. 2001;(4):CD002130. doi: 10.1002/14651858.CD002130. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2010 Sep 08;(9):CD002130. doi: 10.1002/14651858.CD002130.pub2. PMID: 11687143 Updated. Review.
Cited by
-
Impact of Chronic Kidney Disease on the Coronary Revascularization Guided by Intracoronary Physiology: Results of the First Registry with Long-Term Follow-Up in a Latin American Population.J Cardiovasc Dev Dis. 2024 Jul 10;11(7):216. doi: 10.3390/jcdd11070216. J Cardiovasc Dev Dis. 2024. PMID: 39057636 Free PMC article.
-
Combining the Strengths of the Explainable Boosting Machine and Metabolomics Approaches for Biomarker Discovery in Acute Myocardial Infarction.Diagnostics (Basel). 2024 Jun 26;14(13):1353. doi: 10.3390/diagnostics14131353. Diagnostics (Basel). 2024. PMID: 39001243 Free PMC article.
-
The Relationship between Fragmented QRS and Myocardial Injury in Patients with Acute Carbon Monoxide Poisoning.Medicina (Kaunas). 2024 May 28;60(6):891. doi: 10.3390/medicina60060891. Medicina (Kaunas). 2024. PMID: 38929508 Free PMC article.
-
Predictive value of CHA2 DS2 -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.Clin Cardiol. 2023 Aug;46(8):950-957. doi: 10.1002/clc.24071. Epub 2023 Jul 10. Clin Cardiol. 2023. PMID: 37430484 Free PMC article.
-
Creatinine clearance is key to solving the enigma of sex difference in in-hospital mortality after STEMI: Propensity score matching and mediation analysis.PLoS One. 2023 May 3;18(5):e0284668. doi: 10.1371/journal.pone.0284668. eCollection 2023. PLoS One. 2023. PMID: 37134063 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
